Global Keratoconjunctivitis Sicca (Dry Eye) Therapeutics Report 2016: Pipeline Analysis of 38 Companies & 63 Drug Profiles – Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H2 2016" report to their offering. Keratoconjunctivitis sicca (Dry Eye) pipeline therapeutics constitutes close to 63 molecules. Out of which approximately 62 molecules are developed by Companies and remaining by the Universities/Institutes. Keratoconjunctivitis sicca (Dry Eye) Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS) or keratitis